05:17 PM EDT, 06/17/2025 (MT Newswires) -- Stefan Galluppi, Chief Innovation Officer, on June 13, 2025, sold 85,000 shares in LifeMD ( LFMD ) for $1,052,657. Following the Form 4 filing with the SEC, Galluppi has control over a total of 1,725,249 common shares of the company, with 80,449 shares held directly and 1,644,800 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/948320/000091228225000683/xslF345X05/form4.xml